Vaneck UCITS ETFs PLC - Vaneck Genomics And Healthcare Innovators UCITS ETF (LON:CURE)
London · Delayed Price · Currency is GBP · Price in USD 28.16
+1.12 (4.14%)
Last updated: Sep 21, 2026, 12:03 PM GMT
LON:CURE Holdings Information
LON:CURE is an equity ETF with a total of 56 individual holdings. The top holdings are Moderna stock at 11.29%, Natera at 8.30%, Regeneron Pharmaceuticals at 7.81%, Veeva Systems at 7.14%, and Vertex Pharmaceuticals at 6.99%.
Total Holdings
56
Top 10 Percentage
64.73%
Asset Class
Equity
ETF Category
Theme
Assets
15.88M
PE Ratio
28.49
Breakdown by Country
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | MRNA | Moderna, Inc. | 11.29% |
| 2 | NTRA | Natera, Inc. | 8.30% |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | 7.81% |
| 4 | VEEV | Veeva Systems Inc. | 7.14% |
| 5 | VRTX | Vertex Pharmaceuticals Incorporated | 6.99% |
| 6 | DXCM | DexCom, Inc. | 6.26% |
| 7 | ILMN | Illumina, Inc. | 5.52% |
| 8 | GH | Guardant Health, Inc. | 4.63% |
| 9 | BNTX | BioNTech SE | 3.40% |
| 10 | ALNY | Alnylam Pharmaceuticals, Inc. | 3.39% |
| 11 | PODD | Insulet Corporation | 2.03% |
| 12 | QGEN | Qiagen N.V. | 2.00% |
| 13 | ARWR | Arrowhead Pharmaceuticals, Inc. | 1.98% |
| 14 | ASX: PME | Pro Medicus Limited | 1.92% |
| 15 | HKG: 1548 | Genscript Biotech Corporation | 1.85% |
| 16 | TXG | 10x Genomics, Inc. | 1.50% |
| 17 | HKG: 6618 | JD Health International Inc. | 1.48% |
| 18 | CGON | CG Oncology, Inc. | 1.37% |
| 19 | HIMS | Hims & Hers Health, Inc. | 1.30% |
| 20 | KRYS | Krystal Biotech, Inc. | 1.30% |
| 21 | HNGE | Hinge Health, Inc. | 1.29% |
| 22 | CRSP | CRISPR Therapeutics AG | 1.29% |
| 23 | IONS | Ionis Pharmaceuticals, Inc. | 1.23% |
| 24 | TWST | Twist Bioscience Corporation | 1.10% |
| 25 | TYO: 2413 | M3, Inc. | 1.09% |
As of Sep 18, 2026